GO OHE

Dr. GO OHE

Dentistry and Oral surgery, Takamatsu Municipal Hospital
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2018 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
KFKenji Fujisawa
Kenji Fujisawa
KAKazuya Akita
Kazuya Akita
NFNaoyuki Fukuda
Naoyuki Fukuda
KKKumiko Kamada
Kumiko Kamada
TKTakaharu Kudoh
Takaharu Kudoh
YMYouji Miyamoto
Youji Miyamoto

29 August 2018 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Open access
PDF file
MFMasako Fujioka-Kobayashi
Masako Fujioka-Kobayashi
KTKanji Tsuru
Kanji Tsuru
HNHirokazu Nagai
Hirokazu Nagai
KFKenji Fujisawa
Kenji Fujisawa
TKTakaharu Kudoh
Takaharu Kudoh
YMYouji Miyamoto
Youji Miyamoto
Carbonate apatite‐coated calcium carbonate (CO3Ap/CaCO3) was fabricated through a dissolution–precipitation reaction using CaCO3 granules as a precursor to accelerate bone replacement based on superior osteoconductivity of the CO3Ap shell, along with Ca2+ release from the CaCO3 core and quicker resorption of the CaCO3 core. In the present study, CaCO3, 10% CO3Ap/CaCO3, 30% CO3Ap/CaCO3, and CO3Ap granules were fabricated and examined histologically to evaluate their potential as bone substitutes. Larger contents of CaCO3 in the granules resulted in higher Ca2+ release and promoted cell proliferation of murine preosteoblasts at 6 days compared with CO3Ap. Interestingly, in a rabbit femur defect model, 10% CO3Ap/CaCO3 induced significantly higher new bone formation and higher material resorption compared with CO3Ap at 8 weeks. Nevertheless, CO3Ap showed a superior osteoconductive potential compared with 10% CO3Ap/CaCO3 at 8 weeks. All tested granules were most likely resorbed by cell mediation including multinucleated giant cell functions. Therefore, we conclude that CO3Ap/CaCO3 has a positive potential for bone tissue engineering based on well‐controlled calcium release, bone formation, and material resorption.

30 June 2021 in Cancers
Verified
Journal Article
Open access
PDF file
GOGO OHE
GO OHE
Yasusei KudoYasusei Kudo
Yasusei Kudo
KKKumiko Kamada
Kumiko Kamada
YMYasuhiro Mouri
Yasuhiro Mouri
NTNatsumi Takamaru
Natsumi Takamaru
YMYouji Miyamoto
Youji Miyamoto
(1) Background: OK-432 is a penicillin-killed, lyophilized formulation of a low-toxicity strain (Su) of Streptococcus pyogenes (Group A). It is a potent immunotherapy agent for several types of cancer, including oral cancer. We previously showed that (i) OK-432 treatment induces a high amount of IFN-γ production from peripheral blood mononuclear cells (PBMCs), and (ii) conditioned medium (CM) from oral cancer cells suppresses both the IFN-γ production and cytotoxic activity of PBMCs driven by OK-432. The aim of this study was to determine the inhibitory mechanism of OK-432-induced IFN-γ production from PBMCs by CM. (2) Methods: We performed cDNA microarray analysis, quantitative RT-PCR, and ELISA to reveal the inhibitory mechanism of CM. (3) Results: We found that CD40 plays a key role in IFN-γ production via IL-12 production. Although OK-432 treatment upregulated the expression levels of the IL-12p40, p35, and CD40 genes, CM from oral cancer cells downregulate these genes. The amount of IFN-γ production by OK-432 treatment was decreased by an anti-CD40 neutralizing antibody. (4) Conclusions: Our study suggests that uncertain soluble factor(s) produced from oral cancer cells may inhibit IFN-γ production from PBMCs via suppressing the CD40/CD40L–IL-12 axis.